ALLIANCEBERNSTEIN L.P.

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1109448 NASHVILLE, TN

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$552,898

+$411,345 QoQ

Shares Held

55,792

+141.6% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#60

of 183 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. DNA ranks #162 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,019,315	$1,499,784,339
2	ARGX	Argenx SE	395,661	$367,082,405
3	GMAB	Genmab A/S	8,644,877	$237,474,771
4	REGN	Regeneron Pharmaceuticals, Inc.	292,338	$182,284,436
5	TECH	BIO-TECHNE Corp	2,002,026	$141,443,136
6	HALO	Halozyme Therapeutics, Inc.	1,696,538	$132,788,029
7	KYMR	Kymera Therapeutics, Inc.	981,521	$112,551,013
8	BBIO	BridgeBio Pharma, Inc.	1,453,504	$108,256,977

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$552,898	55,792	+141.6%	Shares	Defined	2026-08-14
2026-03-31	$141,553	23,092	0.0%	Shares	Defined	2026-05-15
2025-12-31	$191,894	23,092	0.0%	Shares	Defined	2026-02-17
2025-09-30	$336,681	23,092	-18.1%	Shares	Defined	2025-11-14
2025-06-30	$317,047	28,182	-65.3%	Shares	Defined	2025-08-14
2024-06-30	$27,152	81,294	-82.3%	Shares	Defined	2024-08-14
2024-03-31	$533,542	459,950	+0.5%	Shares	Defined	2024-05-14
2023-12-31	$773,546	457,720	+12.3%	Shares	Defined	2024-02-14
2023-09-30	$737,998	407,734	-0.8%	Shares	Defined	2023-11-14
2023-06-30	$764,487	411,015	+82.1%	Shares	Defined	2023-08-15
2023-03-31	$300,254	225,755	-4.3%	Shares	Defined	2023-05-15
2022-12-31	$398,765	235,956	+18.6%	Shares	Defined	2023-02-15
2022-09-30	$620,705	198,944	-0.9%	Shares	Defined	2022-11-15
2022-06-30	$478,011	200,845	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.